Want to see AIFF full AI Analyst Report?
AIFF Stock Chart & Stats
$1.05
-$0.10(-4.05%)
At close: 4:00 PM EST
$1.05
-$0.10(-4.05%)
Day’s Range― - ―
52-Week Range$0.62 - $3.63
Previous CloseN/A
Volume11.65K
Average Volume (3M)316.76K
Market Cap
$17.32M
Enterprise Value$19.30M
Total Cash (Recent Filing)$3.13M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta1.35
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.68
Shares Outstanding15,605,821
10 Day Avg. Volume358,037
30 Day Avg. Volume316,761
Financial Highlights & Ratios
PEG Ratio-0.03
Price to Book (P/B)1.51
Price to Sales (P/S)10.11
P/FCF Ratio-1.39
Enterprise Value/Market Cap1.11
Enterprise Value/Revenue12.18
Enterprise Value/Gross Profit23.45
Enterprise Value/Ebitda-2.21
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue Growth & Gross MarginSustained high revenue growth with a ~52% gross margin indicates traction for Firefly's AI-driven EEG analytics. Durable gross margins support reinvestment in product and R&D while revenue expansion can drive operating leverage over 2–6 months if scale continues, improving path to profitability.
Debt-free Balance SheetHaving no debt and positive equity reduces immediate solvency risk and preserves strategic flexibility. This structural balance-sheet strength lowers fixed financing costs, allowing management to prioritize growth investments or opportunistic financing without immediate debt-servicing pressure over the coming months.
Refocused AI LeadershipTransitioning the former CTO into a Head of AI role keeps technical expertise while separating governance responsibilities. This structural change can sharpen product execution, accelerate algorithm and biomarker development, and improve long-term R&D focus critical for competitive moat in neurotech.
Bears Say
Severe Cash Burn & LossesExtremely negative margins and deep operating cash outflows mean the business currently consumes material cash to operate. Over 2–6 months this structural cash burn necessitates external funding or steep cost reductions, limiting autonomy and increasing execution risk until operating cash flow improves.
Terminated Financing AgreementThe mutual termination of a planned capital raise creates immediate funding uncertainty. Given persistent cash burn, the structural reliance on capital markets means interrupted financing can force hurried or dilutive raises, delay projects, or constrain marketing and clinical validation timelines.
Negative ROE & Past Negative EquityA deeply negative ROE and history of negative equity signal persistent unprofitability and past dilution. Structurally, this raises the probability future financing will dilute shareholders and indicates the company has yet to achieve sustainable returns on capital, a long-term investor concern.
Firefly Neuroscience News
AIFF FAQ
What was Firefly Neuroscience’s price range in the past 12 months?
Firefly Neuroscience lowest stock price was $0.62 and its highest was $3.63 in the past 12 months.
What is Firefly Neuroscience’s market cap?
Firefly Neuroscience’s market cap is $17.32M.
When is Firefly Neuroscience’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Firefly Neuroscience’s earnings last quarter?
Firefly Neuroscience released its earnings results on May 14, 2024. The company reported -$0.335 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.335.
Is Firefly Neuroscience overvalued?
According to Wall Street analysts Firefly Neuroscience’s price is currently Overvalued.
Does Firefly Neuroscience pay dividends?
Firefly Neuroscience does not currently pay dividends.
What is Firefly Neuroscience’s EPS estimate?
Firefly Neuroscience’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Firefly Neuroscience have?
Firefly Neuroscience has 15,605,821 shares outstanding.
What happened to Firefly Neuroscience’s price movement after its last earnings report?
Firefly Neuroscience reported an EPS of -$0.335 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 5.455%.
Which hedge fund is a major shareholder of Firefly Neuroscience?
Currently, no hedge funds are holding shares in AIFF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Firefly Neuroscience
Based in Toronto, Canada, Firefly Neuroscience, Inc. is a medical technology and artificial intelligence firm specializing in developing neuroscientific solutions. The company's primary goal is to enhance patient outcomes for individuals affected by mental illnesses and neurological disorders. Its flagship product, Brain Network Analytics, is a sophisticated software platform engineered to aid in the diagnosis and treatment of a diverse range of cognitive and psychiatric conditions. These conditions encompass, but are not limited to, depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. Firefly Neuroscience, Inc. caters to both pharmaceutical companies and medical practitioners.
Technical Analysis
Ownership Overview
11.82% Insiders
1.30% Mutual Funds
0.08% Other Institutional Investors
85.78% Public Companies and
Individual Investors